ºÚÁÏÍø

ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
ºÚÁÏÍø

Gastric Cancer

Search results for
Gastric Cancer

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

ºÚÁÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Awards & Nominations
PMC/PubMed Indexed Articles

Publication Policies and Ethics
Citations : 2091

Flyer image
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
View More
Useful Links
Recommended Journals
View More
Related Subjects
View More
Share This Page

Gastric Cancer

Gastric cancer is that the third commonest reason for cancer-related death within the world, and it remains troublesome to cure in Western countries, primarily as a result of most patients gift with advanced sickness. Within the USA abdomen malignancy is presently the fifteenth commonest cancer. The abdomen begins at the internal organ junction and ends at the small intestine. Almost all viscus cancers are adenocarcinomas (cancers that begin in cells that create and unharness mucous secretion and alternative fluids). Alternative kinds of viscus cancer ar duct neoplasm tumors, duct stromal tumors, and lymphomas. Infection with microorganism known as H. pylori may be a common reason for viscus cancer.

Early gastric cancer has no associated symptoms; however, some patients with incidental complaints are diagnosed with early gastric cancer. Most symptoms of gastric cancer reflect advanced disease. All physical signs in gastric cancer are late events. Once the second most common cancer worldwide, stomach cancer has dropped to fourth place, after cancers of the lung, breast, and colon and rectum. However, stomach cancer remains the third most common cause of death from cancer. The World Health Organization estimates that in 2012, gastric cancer accounted for 723,000 deaths worldwide.

Related Journals of Gastric Cancer

Journal of Hepatology and Gastrointestinal disorders, Journal of Gastrointestinal Cancer and Stromal Tumors, Gastric Cancer, Journal of Gastric Cancer.

Gastric Cancer

Expert PPTs

Speaker PPTs

  • Rongtuan Lin
    Modulating the Antioxidant Defences to Potentiate Oncolytic Virotherapy in Refractory Cancer Cells
    | PDF Version
  • Ganapathi Bhat Mugulthimoole
    Unmasking the masquerading cancer cells: have we made progress with the revival of immunotherapy?
    | PDF Version
  • Moshe Giladi
    Tumor Treating Fields (TTFields) induced cancer cell death may be immunogenic resulting in enhanced antitumor efficacy when combined with immune-modulating therapy
    | PDF Version
  • Ping Yang
    Chronic obstructive pulmonary disease (COPD) complicating early-stage lung cancer (LC)
    | PDF Version
  • Daniel S Peiffer
    Dietary consumption of black raspberries or their anthocyanin constituents alters innate immune cell trafficking in esophageal cancer
    | PDF Version
  • Afsar Rahbar
    Studies of the importance of Cytomegalovirus infection in breast cancer
    | PDF Version
  • Mervi Siekkinen
    Effect of e-feedback on knowledge about radiotherapy of breast cancer patients
    | PDF Version
  • Inge Verbrugge
    Radio-immunotherapy of cancer: Therapeutic efficacy, underlying mechanisms and potential applications
    | PDF Version
  • Carolina Alonso-González
    Melatonin sensitizes human breast cancer cells to ionizing radiation
    | PDF Version
  • Guldeniz Karadeniz Cakmak
    The importance of intraoperative ultrasound guidance to achieve negative margins for palpable and nonpalpable breast cancer
    | PDF Version
  • Sribatsa Kumar Mahapatra
    Triple ABC Technique in Clinical Assessment in Breast Cancer Diagnosis
    | PDF Version
  • Daisuke Ota
    The clinical outcome of reconstruction with tissue expander for breast cancer patients with mastectomy
    | PDF Version
  • Nicolae Bacalbasa
    The benefits of surgery for breast cancer liver metastases – a single center experience
    | PDF Version
  • Ozlem Tokusoglu
    Phenolics and Cancer
    | PDF Version
  • Sitanshu Sekhar Lahiri
    A novel oral formulation for cancer therapy, loaded in a slow release matrix for targeted delivery
    | PDF Version
  • Stefan B Eichmüller
    Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1
    | PDF Version
  • Thomas Kieber-Emmons
    Developing a first in man carbohydrate mimetic peptide vaccine for cancer: A translational story
    | PDF Version
  • Yi-Cheng Hu
    Detection of a negative correlation between prescription of Chinese herbal products containing coumestrol, genistein or daidzein and risk of subsequent endometrial cancer among tamoxifentreated female breast cancer survivors in Taiwan between 1998 and 2008: A population-based study
    | PDF Version
  • Daniel H. Snyder
    Breast cancer in young age (≤40 years): The University of Tennessee Medical Center at Knoxville 10 year experience
    | PDF Version
  • Mieke Van Hemelrijck
    A role for lipids and statins in breast cancer risk and prevention?
    | PDF Version
  • Piwen Wang
    Enhanced chemopreventive effect by combining Quercetin and green tea in prostate cancer
    | PDF Version
  • Gaspar Banfalvi
    Origin of breast cancer metastasis
    | PDF Version
  • San Ming Wang
    Unknown genetic predisposition in familial breast cancer can lie deep in family tree
    | PDF Version
  • Vicente Marco
    Changes in breast cancer pathology reports after second opinion
    | PDF Version
  • Christopher Busby
    The breast cancer epidemic: Evidence for a radiogenic cause
    | PDF Version
  • Saroj Velamakanni
    Multiparameter analysis using cell cycle biomarkers for breast cancer: Prognostic and predictive implications
    | PDF Version
  • Benjamin Y. M. Yung
    A Big Data Analysis Platform to Unveil Gene Interactions in Cancer
    | PDF Version
  • Jalal Poorolajal
    The effect of body mass index on endometrial cancer: A meta-analysis
    | PDF Version
  • Tatiana V Macfarlane
    Aspirin use and risk of Head and Neck Cancer: evidence from the INHANCE consortium
    | PDF Version
  • Babak Behnam
    SLUG and SOX9 Cooperatively Regulate Tumor Initiating Niche Factors in Breast Cancer
    | PDF Version
  • Yosef Yarden
    Classically, the 3’untranslated region (3’UTR) is that region in eukaryotic protein-coding genes from the translation termination codon to the polyA signal. It is transcribed as an integral part of the mRNA encoded by the gene. However, there exists another kind of RNA, which consists of the 3’UTR alone, without all other elements in mRNA such as 5’UTR and coding region. The importance of independent 3’UTR RNA (referred as I3’UTR) was prompted by results of artificially introducing such RNA species into malignant mammalian cells. Since 1991, we found that the middle part of the 3’UTR of the human nuclear factor for interleukin-6 (NF-IL6) or C/EBP gene exerted tumor suppression effect in vivo. Our subsequent studies showed that transfection of C/EBP 3’UTR led to down-regulation of several genes favorable for malignancy and to up-regulation of some genes favorable for phenotypic reversion. Also, it was shown that the sequences near the termini of the C/EBP 3’UTR were important for its tumor suppression activity. Then, the C/EBP 3’UTR was found to directly inhibit the phosphorylation activity of protein kinase CPKC in SMMC-7721, a hepatocarcinoma cell line. Recently, an AU-rich region in the C/EBP 3’UTR was found also to be responsible for its tumor suppression. Recently we have also found evidence that the independent C/EBP 3’UTR RNA is actually exists in human tissues, such as fetal liver and heart, pregnant uterus, senescent fibroblasts etc. Through 1990’s to 2000’s, world scientists found several 3’UTR RNAs that functioned as artificial independent RNAs in cancer cells and resulted in tumor suppression. Interestingly, majority of genes for these RNAs have promoter-like structures in their 3’UTR regions, although the existence of their transcribed products as independent 3’UTR RNAs is still to be confirmed. Our studies indicate that the independent 3’UTR RNA is a novel non-coding RNA species whose function should be the regulation not of the expression of their original mRNA, but of some essential life activities of the cell as a whole.
    | PDF Version
  • Suoqin Tang
    Survivin siRNA nano particles are capable of inhibiting liver cancer cell growth both in vitro and in vivo
    | PDF Version
  • Eli Raveh
    From chromosomal instability to metastases- H19’s role in cancer progression and its clinical significance
    | PDF Version
  • Hugo Albrecht
    Towards pharmacological validation of MNKs as anti-cancer drug targets
    | PDF Version
  • Wei Duan
    Cancer stem cells targeted delivery of siRNA to overcome induced chemoresistance
    | PDF Version
  • Lourdes Cortes Dericks
    Cancer Stem Cell Markers in Lung Cancer: Proofs of Concept and Some Reservations
    | PDF Version
  • Huidi Liu
    Reduced Expression of SOX7 in Ovarian Cancer: a Novel Tumor Suppressor through the Wnt/β-catenin Signaling Pathway
    | PDF Version
  • Isabelle De Waziers
    Use of engineered mesenchymal stem cells against cancers
    | PDF Version
  • Soha M Hamdy
    Biochemical studies on the effect of turmeric on breast cancer of rats
    | PDF Version
  • Maria da Graça Justo Araujo
    Fanconi anemia: Immune deficiency and susceptibility to cancer
    | PDF Version
  • Pi-Wan Cheng
    Disregulation of Golgi localization of glycosyltransferases alters mucin O-glycosylation and survival or metastatic properties of cancer cells
    | PDF Version
  • Sourav Sarkar
    MUC1 glycopeptide based anti-cancer vaccines
    | PDF Version
  • Medhat Faris
    Patient advocacy program for breast cancer patients in the eastern province
    | PDF Version
  • Jose Roberto Piato
    Improved frozen section examination of the retroareolar margin for prediction of nipple involvement in breast cancer
    | PDF Version
  • Ewa Maj
    Antiangiogenic treatment in non-small cell lung cancer (NSCLC)
    | PDF Version
  • James A Bonner
    Anti-EGFr monoclonal antibody therapy in Head and Neck cancer
    | PDF Version
  • Francis Mussai
    Tumour arginine addiction subverts the anti-cancer immune response
    | PDF Version
  • Saif Uddin Ahmed
    Breast Cancer: Presentation & limitation oftreatment - Bangladesh perspective
    | PDF Version
  • Punit Kaur
    A Mouse Model for Triple-Negative Breast Cancer Stem Cells (TNBC-CSC) Exhibits an Aggressive Phenotype
    | PDF Version
  • Matthew Curzon, M.D.
    Breast cancer in elderly patients (70 years and older): The University of Tennessee Medical Center at Knoxville 10 year experience
    | PDF Version
  • Heather Gage
    HER2+ breast cancer: Pre and post adjuvant anti-HER2 therapy era - the University of Tennessee Medical Center at Knoxville 11 year experience
    | PDF Version
  • Peter Weightman
    A new approach to the diagnosis of cervical, oesophageal and prostate cancer based on a combination of infrared and terahertz techniques
    | PDF Version
  • Fabienne Meier-Abt
    Mechanisms of Early Pregnancy-Mediated Breast Cancer Protection
    | PDF Version
  • Federico Cattin
    Breast cancer: A comparison among different diagnostic and therapeutic protocols
    | PDF Version
  • Lei Huo
    Diagnostic biomarkers in metastatic breast cancer
    | PDF Version
  • Shareef Alqahtani
    Illitracy and Breast Cancer Screening Utilization: A Case Study of Saudi Women over 60 Years of Age
    | PDF Version
  • Arghya Adhikary
    PEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34a
    | PDF Version
  • Amila Orucevic
    Prognostic value of ER, PR, and HER2 breast cancer biomarkers and AJCC’s TNM staging system on overall survival of Caucasian females with breast cancer: An institution’s 10 year experience
    | PDF Version
  • Phillip K. Darcy
    Cancer immunotherapy utilizing gene-modified T cells: from the bench to the clinic.
    | PDF Version
  • Yvonne Paterson
    HER-2/neu as a target forListeria-based cancer immunotherapy for breast cancer
    | PDF Version
  • Caigang Liu
    FSIP1: A new potential early screening marker for breast cancer
    | PDF Version
  • Domenico Samorani
    Screening of Breast Cancer from Mammography to MR Imaging
    | PDF Version
  • Diptendra K Sarkar
    Role of NFKB as a prognostic marker in breast cancer: a new tool in the horizon
    | PDF Version
  • S Karthikeyan
    Resveratrol modulates expression of ABC transporters in non-small lung cancer cells: Molecular docking and gene expression studies
    | PDF Version
  • Sushmita Pathy
    Role of Radiotherapy in Multidisciplinary Management of Rectal Cancers
    | PDF Version
  • Dashrath Ram N Reddy
    Role of Nutraceuticals in chemoprevention and cancer treatment
    | PDF Version
  • Praveen Kumar Saxena
    Metal Burden -Cancer
    | PDF Version
  • Pravin D Potdar
    Molecular Profiling of Cancer Cells
    | PDF Version
  • Shaqul Qamar Wani
    Cervical Cancer: An update on the guidelines for screening
    | PDF Version
  • Amany Mohammed Shebl
    Impact of nursing management protocol on radiotherapy induced git side effects (nausea, vomiting, and diarrhea) in patients with cancer
    | PDF Version
  • Kevin Carvalho de Melo Faria
    Laparoscopic Gastrectomy for Gastric Cancer Treatment: Report of an Initial Experience
    | PDF Version
  • Peiying Yang
    Role of Na, K-ATPase in Gastrointestinal Cancer
    | PDF Version
  • Almas Okassov
    Chemical modification of anticancer Parasporins for decreasing of their toxicity
    | PDF Version
  • Alvaro Ronco
    Nutriequalization: Attempting to improve survival in cancer patients through nutritional modifications
    | PDF Version
  • Antonio Cilla
    Antiproliferative effect of main dietary phytosterols and/or β-cryptoxanthin in human colon cancer Caco-2 cells through cytosolic Ca2+ - and oxidative stress-induced apoptosis
    | PDF Version
  • Vineeta Deshmukh
    Effectiveness of Ayurvedic treatment in alleviating side-effects of radiotherapy in oropharyngeal cancer patients and its relationship with improvement in immune status of the host
    | PDF Version
  • Mingsong Wu
    Identification of differentially expressed genes in human lung adenocarcinoma: ERGIC3 as a novel lung cancer-related gene
    | PDF Version
  • Dean A
    Identifying physical and psycho-social issues facing breast cancer survivors after definitive treatment for early breast cancer: a nurse-led clinic model
    | PDF Version
  • SinYoung Kim
    Health beliefs and breast cancer screening among Korean immigrant women
    | PDF Version
  • Shulamith Kreitler
    Where, when and how to die: Insights into issues of critical nursing in cancer
    | PDF Version
  • Liselotte Jakobsson
    Does a salutogenic attitude increase life quality after prostate cancer treatment?
    | PDF Version
  • Adriana Katz
    Na,K-ATPase isoform-selective cardiac glycosides- a potential anti-cancer drug ?
    | PDF Version
  • Tamar Geiger
    Genome-Scale Proteomic Profiling of Breast Cancer Progression
    | PDF Version
  • Chien-Fu Hung
    Mark cancer cells for CTL attack through coating with viral antigenic peptides CTLs kill tumor with viral peptides
    | PDF Version
  • Rahul Purwar
    Engineered T cells: Next-generation cancer immunotherapy
    | PDF Version
  • John A. Barrett
    Localized regulated expression of IL-12 as a gene therapy approach to cancer immunotherapy
    | PDF Version
  • Tao Lu
    Using VBIM technique to identify drug resistance genes in ovarian cancer
    | PDF Version
  • Lydia Benhocine
    Cancers, chemotherapies and hemodialysis: A retrospective study
    | PDF Version
  • RanjitaPallavi
    Geriatric Oncology: Caring for the older patient with cancer
    | PDF Version
  • Lourdes Cortes-Dericks
    ALDHhigh/CD44+ putative cancer stem cell population as therapeutic target in malignant pleural mesothelioma
    | PDF Version
  • Mark D Gorrell
    The protease fibroblast activation proteinas a biomarker and therapeutic target in cancer and chronic liver injury
    | PDF Version
  • Daniel Rotroff
    Using DNA copy number aberrations in naturally occurring canine cancers to identify candidate drivers of carcinogenesis
    | PDF Version
  • Ivan Mfouo-Tynga
    Effects of SulfonatedZinc Phthalocyanine and Low Intensity Laser Irradiation in Inducing Photodynamic Damagein Breast Cancer Cells
    | PDF Version
  • Mark Kester
    Nanocolloidsfor Cancer
    | PDF Version
  • Yajun Yi
    Meta-analysis of transcriptional profiles in cancer for prognosis prediction and metastatic gene identification
    | PDF Version
  • Vladimir Pak
    Double Targeting as an Effective Anti-Cancer Strategy
    | PDF Version
  • Luminita Castillos
    Gene expression profiling for targeted cancer treatment
    | PDF Version
  • Anton Yuryev
    Construction of cancer pathways for personalized medicine
    | PDF Version
  • Jung-Joon Min
    Bacteria-mediated expression of cargo drugs and reporter gene for cancer-specific theranostics
    | PDF Version
  • Maria Paola COSTI
    A proteomic-bioinformatic integrated approach for studying the effect of a peptide drug candidate on ovarian Cancer
    | PDF Version
  • Bing Zhang
    Translating multidimensional cancer omics data into biological insights
    | PDF Version
  • Vladimir Torchilin
    Stimuli-sensitive combination nanopreparations of siRNA and chemotherapeutic drugs to treat multidrug resistant cancer
    | PDF Version
  • Kelvin K. Tsai
    Linking tissue microarchitectures to rationalized molecular diagnostics in glandular cancers
    | PDF Version
  • Zuping Xia
    Development of Sphingosine Kinase Inhibitors for Cancer Therapy
    | PDF Version
  • Charles F. L. Mbakaya
    Elucidating the link between environment, nutrition, host immunity, AIDS and cancer as informed by selected studies in Kenya and beyond
    | PDF Version
High Impact List of Articles
Conference Proceedings